MovDisordV3, Pmc, Checkpoint, bibRecord, 000256

MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI

Identifieur interne : 000256 ( Pmc/Checkpoint ); précédent : 000255; suivant : 000257

MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI

Auteurs : I. Litvan [États-Unis] ; D. Aarsland ; Ch Adler [États-Unis] ; Jg Goldman [États-Unis] ; J. Kulisevsky [Espagne] ; B. Mollenhauer [Allemagne] ; Mc Rodriguez-Oroz [Espagne] ; Ai Tröster [États-Unis] ; D. Weintraub [États-Unis]

Source :

Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2011.

RBID : PMC:3181006

Abstract

Background

There is controversy regarding the definition and characteristics of mild cognitive impairment in Parkinson’s disease.

Objective

The Movement Disorders Society commissioned a Task Force to critically evaluate the literature and determine the frequency and characteristics of Parkinson’s disease-mild cognitive impairment and its association with dementia.

Methods

Comprehensive PubMed literature review using systematic inclusion and exclusion criteria.

Results

A mean of 26.7% (range, 18.9–38.2%) of non-demented Parkinson’s disease patients have mild cognitive impairment. The frequency of Parkinson’s disease mild cognitive impairment increases with age, disease duration, and disease severity. Impairments occur in a range of cognitive domains, but single domain impairment is more common than multiple domain impairment, and within single domain impairment, non-amnestic is more common than amnestic impairment. A high proportion of patients with Parkinson’s disease-mild cognitive impairment progress to dementia in a relatively short period of time.

Conclusions

The primary conclusions of the Task Force are that: (1) Parkinson’s disease-mild cognitive impairment is common; (2) there is significant heterogeneity within Parkinson’s disease-mild cognitive impairment in the number and types of cognitive domain impairments; (3) Parkinson’s disease-mild cognitive impairment appears to place patients at risk of progressing to dementia; and (4) formal diagnostic criteria for Parkinson’s disease-mild cognitive impairment are needed.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181006

DOI: 10.1002/mds.23823
PubMed: 21661055
PubMed Central: 3181006

Affiliations:

Allemagne, Espagne, États-Unis
Arizona, Caroline du Nord, Illinois, Kentucky, Pennsylvanie

Links toward previous steps (curation, corpus...)

to stream Pmc, to step Corpus: 000181
to stream Pmc, to step Curation: 000181

Links to Exploration step

PMC:3181006

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI</title>
<author><name sortKey="Litvan, I" sort="Litvan, I" uniqKey="Litvan I" first="I" last="Litvan">I. Litvan</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, KY, USA and Movement Disorders Program, Frazier Rehab Neuroscience Institute, Louisville, KY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Kentucky</region>
</placeName>
<wicri:cityArea> Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, KY, USA and Movement Disorders Program, Frazier Rehab Neuroscience Institute, Louisville</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Aarsland, D" sort="Aarsland, D" uniqKey="Aarsland D" first="D" last="Aarsland">D. Aarsland</name>
<affiliation><nlm:aff id="A2"> Centre for Age-Related Medicine, Stavanger University Hospital and Akershus University Hospital/University of Oslo</nlm:aff>
<wicri:noCountry code="subfield">Stavanger University Hospital and Akershus University Hospital/University of Oslo</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Adler, Ch" sort="Adler, Ch" uniqKey="Adler C" first="Ch" last="Adler">Ch Adler</name>
<affiliation wicri:level="2"><nlm:aff id="A3"> Parkinson’s Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Parkinson’s Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, AZ</wicri:regionArea>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Goldman, Jg" sort="Goldman, Jg" uniqKey="Goldman J" first="Jg" last="Goldman">Jg Goldman</name>
<affiliation wicri:level="2"><nlm:aff id="A4"> Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL</wicri:regionArea>
<placeName><region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kulisevsky, J" sort="Kulisevsky, J" uniqKey="Kulisevsky J" first="J" last="Kulisevsky">J. Kulisevsky</name>
<affiliation wicri:level="1"><nlm:aff id="A5"> Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea> Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)</wicri:regionArea>
<wicri:noRegion>Universitat Autònoma de Barcelona and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mollenhauer, B" sort="Mollenhauer, B" uniqKey="Mollenhauer B" first="B" last="Mollenhauer">B. Mollenhauer</name>
<affiliation wicri:level="1"><nlm:aff id="A6"> Paracelsus-Elena-Klinik, Kassel and Georg-August University Goettingen, Germany</nlm:aff>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea> Paracelsus-Elena-Klinik, Kassel and Georg-August University Goettingen</wicri:regionArea>
<wicri:noRegion>Kassel and Georg-August University Goettingen</wicri:noRegion>
<wicri:noRegion>Kassel and Georg-August University Goettingen</wicri:noRegion>
<wicri:noRegion>Kassel and Georg-August University Goettingen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rodriguez Oroz, Mc" sort="Rodriguez Oroz, Mc" uniqKey="Rodriguez Oroz M" first="Mc" last="Rodriguez-Oroz">Mc Rodriguez-Oroz</name>
<affiliation wicri:level="1"><nlm:aff id="A7"> Department of Neurology, Clinic Universidad de Navarra, Medical School, Neuroscience Center, CIMA, Pamplona, Centros de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea> Department of Neurology, Clinic Universidad de Navarra, Medical School, Neuroscience Center, CIMA, Pamplona, Centros de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)</wicri:regionArea>
<wicri:noRegion>Centros de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Troster, Ai" sort="Troster, Ai" uniqKey="Troster A" first="Ai" last="Tröster">Ai Tröster</name>
<affiliation wicri:level="2"><nlm:aff id="A8"> Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC</wicri:regionArea>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Weintraub, D" sort="Weintraub, D" uniqKey="Weintraub D" first="D" last="Weintraub">D. Weintraub</name>
<affiliation wicri:level="2"><nlm:aff id="A9"> Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine; Parkinson’s Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine; Parkinson’s Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">21661055</idno>
<idno type="pmc">3181006</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181006</idno>
<idno type="RBID">PMC:3181006</idno>
<idno type="doi">10.1002/mds.23823</idno>
<date when="2011">2011</date>
<idno type="wicri:Area/Pmc/Corpus">000181</idno>
<idno type="wicri:Area/Pmc/Curation">000181</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000256</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI</title>
<author><name sortKey="Litvan, I" sort="Litvan, I" uniqKey="Litvan I" first="I" last="Litvan">I. Litvan</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, KY, USA and Movement Disorders Program, Frazier Rehab Neuroscience Institute, Louisville, KY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Kentucky</region>
</placeName>
<wicri:cityArea> Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, KY, USA and Movement Disorders Program, Frazier Rehab Neuroscience Institute, Louisville</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Aarsland, D" sort="Aarsland, D" uniqKey="Aarsland D" first="D" last="Aarsland">D. Aarsland</name>
<affiliation><nlm:aff id="A2"> Centre for Age-Related Medicine, Stavanger University Hospital and Akershus University Hospital/University of Oslo</nlm:aff>
<wicri:noCountry code="subfield">Stavanger University Hospital and Akershus University Hospital/University of Oslo</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Adler, Ch" sort="Adler, Ch" uniqKey="Adler C" first="Ch" last="Adler">Ch Adler</name>
<affiliation wicri:level="2"><nlm:aff id="A3"> Parkinson’s Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Parkinson’s Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, AZ</wicri:regionArea>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Goldman, Jg" sort="Goldman, Jg" uniqKey="Goldman J" first="Jg" last="Goldman">Jg Goldman</name>
<affiliation wicri:level="2"><nlm:aff id="A4"> Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL</wicri:regionArea>
<placeName><region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kulisevsky, J" sort="Kulisevsky, J" uniqKey="Kulisevsky J" first="J" last="Kulisevsky">J. Kulisevsky</name>
<affiliation wicri:level="1"><nlm:aff id="A5"> Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea> Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)</wicri:regionArea>
<wicri:noRegion>Universitat Autònoma de Barcelona and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mollenhauer, B" sort="Mollenhauer, B" uniqKey="Mollenhauer B" first="B" last="Mollenhauer">B. Mollenhauer</name>
<affiliation wicri:level="1"><nlm:aff id="A6"> Paracelsus-Elena-Klinik, Kassel and Georg-August University Goettingen, Germany</nlm:aff>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea> Paracelsus-Elena-Klinik, Kassel and Georg-August University Goettingen</wicri:regionArea>
<wicri:noRegion>Kassel and Georg-August University Goettingen</wicri:noRegion>
<wicri:noRegion>Kassel and Georg-August University Goettingen</wicri:noRegion>
<wicri:noRegion>Kassel and Georg-August University Goettingen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rodriguez Oroz, Mc" sort="Rodriguez Oroz, Mc" uniqKey="Rodriguez Oroz M" first="Mc" last="Rodriguez-Oroz">Mc Rodriguez-Oroz</name>
<affiliation wicri:level="1"><nlm:aff id="A7"> Department of Neurology, Clinic Universidad de Navarra, Medical School, Neuroscience Center, CIMA, Pamplona, Centros de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea> Department of Neurology, Clinic Universidad de Navarra, Medical School, Neuroscience Center, CIMA, Pamplona, Centros de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)</wicri:regionArea>
<wicri:noRegion>Centros de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Troster, Ai" sort="Troster, Ai" uniqKey="Troster A" first="Ai" last="Tröster">Ai Tröster</name>
<affiliation wicri:level="2"><nlm:aff id="A8"> Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC</wicri:regionArea>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Weintraub, D" sort="Weintraub, D" uniqKey="Weintraub D" first="D" last="Weintraub">D. Weintraub</name>
<affiliation wicri:level="2"><nlm:aff id="A9"> Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine; Parkinson’s Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine; Parkinson’s Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="S1"><title>Background</title>
<p id="P1">There is controversy regarding the definition and characteristics of mild cognitive impairment in Parkinson’s disease.</p>
</sec>
<sec id="S2"><title>Objective</title>
<p id="P2">The Movement Disorders Society commissioned a Task Force to critically evaluate the literature and determine the frequency and characteristics of Parkinson’s disease-mild cognitive impairment and its association with dementia.</p>
</sec>
<sec sec-type="methods" id="S3"><title>Methods</title>
<p id="P3">Comprehensive PubMed literature review using systematic inclusion and exclusion criteria.</p>
</sec>
<sec id="S4"><title>Results</title>
<p id="P4">A mean of 26.7% (range, 18.9–38.2%) of non-demented Parkinson’s disease patients have mild cognitive impairment. The frequency of Parkinson’s disease mild cognitive impairment increases with age, disease duration, and disease severity. Impairments occur in a range of cognitive domains, but single domain impairment is more common than multiple domain impairment, and within single domain impairment, non-amnestic is more common than amnestic impairment. A high proportion of patients with Parkinson’s disease-mild cognitive impairment progress to dementia in a relatively short period of time.</p>
</sec>
<sec id="S5"><title>Conclusions</title>
<p id="P5">The primary conclusions of the Task Force are that: (1) Parkinson’s disease-mild cognitive impairment is common; (2) there is significant heterogeneity within Parkinson’s disease-mild cognitive impairment in the number and types of cognitive domain impairments; (3) Parkinson’s disease-mild cognitive impairment appears to place patients at risk of progressing to dementia; and (4) formal diagnostic criteria for Parkinson’s disease-mild cognitive impairment are needed.</p>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article" xml:lang="en"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
  <pmc-dir>properties manuscript</pmc-dir>
  <front><journal-meta><journal-id journal-id-type="nlm-journal-id">8610688</journal-id>
<journal-id journal-id-type="pubmed-jr-id">5937</journal-id>
<journal-id journal-id-type="nlm-ta">Mov Disord</journal-id>
<journal-title-group><journal-title>Movement disorders : official journal of the Movement Disorder Society</journal-title>
</journal-title-group>
<issn pub-type="ppub">0885-3185</issn>
<issn pub-type="epub">1531-8257</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">21661055</article-id>
<article-id pub-id-type="pmc">3181006</article-id>
<article-id pub-id-type="doi">10.1002/mds.23823</article-id>
<article-id pub-id-type="manuscript">NIHMS296543</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Litvan</surname>
<given-names>I</given-names>
</name>
<xref rid="A1" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Aarsland</surname>
<given-names>D</given-names>
</name>
<xref rid="A2" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Adler</surname>
<given-names>CH</given-names>
</name>
<xref rid="A3" ref-type="aff">3</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Goldman</surname>
<given-names>JG</given-names>
</name>
<xref rid="A4" ref-type="aff">4</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Kulisevsky</surname>
<given-names>J</given-names>
</name>
<xref rid="A5" ref-type="aff">5</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Mollenhauer</surname>
<given-names>B</given-names>
</name>
<xref rid="A6" ref-type="aff">6</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Rodriguez-Oroz</surname>
<given-names>MC</given-names>
</name>
<xref rid="A7" ref-type="aff">7</xref>
<xref rid="FN1" ref-type="author-notes">*</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Tröster</surname>
<given-names>AI</given-names>
</name>
<xref rid="A8" ref-type="aff">8</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Weintraub</surname>
<given-names>D</given-names>
</name>
<xref rid="A9" ref-type="aff">9</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>
 Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, KY, USA and Movement Disorders Program, Frazier Rehab Neuroscience Institute, Louisville, KY</aff>
<aff id="A2"><label>2</label>
 Centre for Age-Related Medicine, Stavanger University Hospital and Akershus University Hospital/University of Oslo</aff>
<aff id="A3"><label>3</label>
 Parkinson’s Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA</aff>
<aff id="A4"><label>4</label>
 Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA</aff>
<aff id="A5"><label>5</label>
 Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain</aff>
<aff id="A6"><label>6</label>
 Paracelsus-Elena-Klinik, Kassel and Georg-August University Goettingen, Germany</aff>
<aff id="A7"><label>7</label>
 Department of Neurology, Clinic Universidad de Navarra, Medical School, Neuroscience Center, CIMA, Pamplona, Centros de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain</aff>
<aff id="A8"><label>8</label>
 Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA</aff>
<aff id="A9"><label>9</label>
 Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine; Parkinson’s Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA</aff>
<author-notes><fn id="FN1" fn-type="present-address"><label>*</label>
<p>Current address: Department of Neurology, Hospital Donostia and BioDonostia, San Sebastian, Spain.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted"><day>16</day>
<month>5</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="epub"><day>9</day>
<month>6</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="ppub"><day>15</day>
<month>8</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>15</day>
<month>8</month>
<year>2012</year>
</pub-date>
<volume>26</volume>
<issue>10</issue>
<fpage>1814</fpage>
<lpage>1824</lpage>
<abstract><sec id="S1"><title>Background</title>
<p id="P1">There is controversy regarding the definition and characteristics of mild cognitive impairment in Parkinson’s disease.</p>
</sec>
<sec id="S2"><title>Objective</title>
<p id="P2">The Movement Disorders Society commissioned a Task Force to critically evaluate the literature and determine the frequency and characteristics of Parkinson’s disease-mild cognitive impairment and its association with dementia.</p>
</sec>
<sec sec-type="methods" id="S3"><title>Methods</title>
<p id="P3">Comprehensive PubMed literature review using systematic inclusion and exclusion criteria.</p>
</sec>
<sec id="S4"><title>Results</title>
<p id="P4">A mean of 26.7% (range, 18.9–38.2%) of non-demented Parkinson’s disease patients have mild cognitive impairment. The frequency of Parkinson’s disease mild cognitive impairment increases with age, disease duration, and disease severity. Impairments occur in a range of cognitive domains, but single domain impairment is more common than multiple domain impairment, and within single domain impairment, non-amnestic is more common than amnestic impairment. A high proportion of patients with Parkinson’s disease-mild cognitive impairment progress to dementia in a relatively short period of time.</p>
</sec>
<sec id="S5"><title>Conclusions</title>
<p id="P5">The primary conclusions of the Task Force are that: (1) Parkinson’s disease-mild cognitive impairment is common; (2) there is significant heterogeneity within Parkinson’s disease-mild cognitive impairment in the number and types of cognitive domain impairments; (3) Parkinson’s disease-mild cognitive impairment appears to place patients at risk of progressing to dementia; and (4) formal diagnostic criteria for Parkinson’s disease-mild cognitive impairment are needed.</p>
</sec>
</abstract>
<kwd-group><kwd>mild cognitive impairment</kwd>
<kwd>Parkinson’s disease</kwd>
<kwd>systematic review</kwd>
</kwd-group>
<funding-group><award-group><funding-source country="United States">National Institute on Aging  : NIA</funding-source>
<award-id>R01 AG024040-05 || AG</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</pmc>
<affiliations><list><country><li>Allemagne</li>
<li>Espagne</li>
<li>États-Unis</li>
</country>
<region><li>Arizona</li>
<li>Caroline du Nord</li>
<li>Illinois</li>
<li>Kentucky</li>
<li>Pennsylvanie</li>
</region>
</list>
<tree><noCountry><name sortKey="Aarsland, D" sort="Aarsland, D" uniqKey="Aarsland D" first="D" last="Aarsland">D. Aarsland</name>
</noCountry>
<country name="États-Unis"><region name="Kentucky"><name sortKey="Litvan, I" sort="Litvan, I" uniqKey="Litvan I" first="I" last="Litvan">I. Litvan</name>
</region>
<name sortKey="Adler, Ch" sort="Adler, Ch" uniqKey="Adler C" first="Ch" last="Adler">Ch Adler</name>
<name sortKey="Goldman, Jg" sort="Goldman, Jg" uniqKey="Goldman J" first="Jg" last="Goldman">Jg Goldman</name>
<name sortKey="Troster, Ai" sort="Troster, Ai" uniqKey="Troster A" first="Ai" last="Tröster">Ai Tröster</name>
<name sortKey="Weintraub, D" sort="Weintraub, D" uniqKey="Weintraub D" first="D" last="Weintraub">D. Weintraub</name>
</country>
<country name="Espagne"><noRegion><name sortKey="Kulisevsky, J" sort="Kulisevsky, J" uniqKey="Kulisevsky J" first="J" last="Kulisevsky">J. Kulisevsky</name>
</noRegion>
<name sortKey="Rodriguez Oroz, Mc" sort="Rodriguez Oroz, Mc" uniqKey="Rodriguez Oroz M" first="Mc" last="Rodriguez-Oroz">Mc Rodriguez-Oroz</name>
</country>
<country name="Allemagne"><noRegion><name sortKey="Mollenhauer, B" sort="Mollenhauer, B" uniqKey="Mollenhauer B" first="B" last="Mollenhauer">B. Mollenhauer</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Pmc/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000256 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000256 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Pmc
   |étape=   Checkpoint
   |type=    RBID
   |clé=     PMC:3181006
   |texte=   MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i   -Sk "pubmed:21661055" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI

MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI

Source :

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki